Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Spier Isabel, Yin Xiaoyu, Richardson Marcy, Pineda Marta, Laner Andreas, Ritter Deborah, Boyle Julie, Mur Pilar, Hansen Thomas V O, Shi Xuemei, Mahmood Khalid, Plazzer John-Paul, Ognedal Elisabet, Nordling Margareta, Farrington Susan M, Yamamoto Gou, Baert-Desurmont Stéphanie, Martins Alexandra, Borras Ester, Tops Carli, Webb Erica, Beshay Victoria, Genuardi Maurizio, Pesaran Tina, Capellá Gabriel, Tavtigian Sean V, Latchford Andrew, Frayling Ian M, Plon Sharon E, Greenblatt Marc, Macrae Finlay A, Aretz Stefan, InSiGHT-ClinGen Hereditary Colon Cancer/Polyposis Variant Curation Expert Panel
Аннотация
METHODS: Through a rigorous process of database analysis, literature review, and expert elicitation, the APC VCEP derived gene-specific modifications to the ACMG/AMP (American College of Medical Genetics and Genomics and Association for Molecular Pathology) variant classification guidelines and validated such criteria through the pilot classification of 58 variants.
RESULTS: The APC-specific criteria represented gene- and disease-informed specifications, including a quantitative approach to allele frequency thresholds, a stepwise decision tool for truncating variants, and semiquantitative evaluations of experimental and clinical data. Using the APC-specific criteria, 47% (27/58) of pilot variants were reclassified including 14 previous variants of uncertain significance (VUS).
CONCLUSION: The APC-specific ACMG/AMP criteria preserved the classification of well-characterized variants on ClinVar while substantially reducing the number of VUS by 56% (14/25). Moving forward, the APC VCEP will continue to interpret prioritized lists of VUS, the results of which will represent the most authoritative variant classification for widespread clinical use.